Search Results
Search results for "Juan Jose Fung"
Results found for "Juan Jose Fung"
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
dynamics of hM3Dq [Ca2+]i signaling, increased cell proliferation, and enhanced matrix production in a CNO dose
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben, Kuang, Wang & Kong, 2016; Kuang, Feng GPCR-related knowledge, AI can help identify patient-specific GPCR targets and optimize drug selection and dosing
- đź“° GPCR Weekly News
Leuven to Identify and Validate Key GPCRs Driving Gastrointestinal and Immune Disorders Inversago Pharma Doses
- đź“° GPCR Weekly News, March 18 to 24, 2024
uncovering the natural mutations of L->Q, I->T, F->Y and Q->L, T->I and Y->F Industry News Sosei Heptares Doses
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
From insight to funding, clarity turns analysis into investor confidence How IP Expectations Are Evolving Investors want to understand sooner how intellectual property supports the business they are being asked to fund
- Domain Therapeutics Raises $42m Series A Financing
$42m (€39m) series A financing round co-led by Panacea Venture, CTI Life Sciences and 3B Future Health Fund
- The sixth transmembrane region of a pheromone G-protein coupled receptor, Map3, is implicated in ...
In ascomycete fungi including yeasts, mating between cells of opposite mating type depends on the molecular
- đź“° GPCR Weekly News, June 24 to 30, 2024
Kawthar Belkacemi, Philippe Rondard, Jean-Philippe Pin, and Laurent Prézeau, for their research on Heterodimers
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
lesson shows how to replace inference with models that disentangle mechanism—so your next go/no-go, dose
- đź“° GPCR Weekly News, April 22 to 28, 2024
transmembrane proteome profiling in mental disease models Reviews, GPCRs, and more The nematode-trapping fungus prey pheromones via G protein-coupled receptors Structural and Molecular Insights into GPCR Function Fungal
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
US $900,000) of additional research funding.
- đź“° GPCR Weekly News, June 5 to 11, 2023
EyeBio Announces First Patients Dosed in Phase 1b/2 Trial of Restoret™ in Neovascular Age Related Macular
- đź“° GPCR Weekly News, January 15 to 21, 2024
Receptor Gpr-1 Is Important for the Growth and Nutritional Metabolism of an Invasive Bark Beetle Symbiont Fungi
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
Opportunities and hurdles for clinical development 👨‍💻 Why would you want to miss out on all the fun Enter Collaboration To Design Novel GPCR- Targeted Antibody Therapeutics Using Generative AI Zombie Fungi
- From Snapshots to Predictions: Why Mechanism of Action Matters
If you’ve ever stared at a dose–response curve and wondered, “Is this partial agonism?
- 4GPCRnet - International Symposium
Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded
- đź“° GPCR Weekly News, September 11 to 17, 2023
receptor sensor GPCRs in Oncology and Immunology Phase 1/2 study of sorafenib added to cladribine, high-dose
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
In 2016 the company was sold to Velocity fund partners and has been rebranded as InClinica.
- đź“° GPCR Weekly News, July 31 to August 6, 2023
and Immunology GPCRs and fibroblast heterogeneity in fibroblast-associated diseases Ultrasensitive dose-response neuropeptide transmission Nanowire Biosensors with Olfactory Proteins: Towards a genuine electronic nose
- The Imprecision Problem: Why Your GPCR Drug Discovery Program Is Off-Track Before It Even Starts
A GPCR program can have world-class science, top-tier talent, and millions in funding — and still fail
- Allosteric Binding Data Interpretation in Complex Receptor Systems
curve—long treated as a signature of competitive interaction—retains its shape in allosteric systems but loses Escalating dose does not improve inhibition because the system has reached its structural limit.
- From Switches to Microcircuits: GPCR Biased Signaling and the Future of Drug Discovery
 in vivo  and its relation to EC50 values defined in functional assays is essential for meaningful dose-response
- Why Fundraising Mistakes Kill Strong Biotech Startups
. 👉 This is why strong biotech startups often appear busiest right before they lose momentum. Clarity does not follow funding. Funding follows clarity. This is why strong biotech startups can lose their strategic center without any dramatic turning point They lose their edge when fundraising quietly becomes the logic behind everyday choices , replacing strategy When fundraising leads and strategy reacts, even strong biotech startups slowly lose coherence. ✅ The
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
Rafael Rivas-Santisteban , Ana Muñoz , Jaume Lillo , Iu RaĂŻch , Ana RodrĂguez-PĂ©rez , Gemma Navarro , JosĂ© inhibitor, suppresses the TGF-α-induced migration of hepatocellular carcinoma cells via inhibition of the c-Jun
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
structure and activation mechanisms of GPCRs, the biotech investment community has injected significant funding Twice-daily treatment with mOB-004 dose-dependently suppressed monocyte infiltration into the peritoneum cavity, achieving complete blockade at the highest dose level.
- GPCRs are not simple on-off switches: deep dive into GPCR-ligand interactions
1984 (Cerione et al. 1984), where reconstitution of purified β2-adrenergic receptors from guinea pig lung of adjustability in terms of pharmacological effects, allowing for the administration of substantial doses
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
Alexander S Hauser Calcineurin-fusion facilitates cryo-EM structure determination of a Family A GPCR Jun tagging and interrogation of GPCR co-internalization Kilian RoĂźmann , Ramona Birke , Joshua Levitz , Ben Jones
- đź“° GPCR Weekly News, October 2 to 8, 2023
at symposium honoring Nobel Laureate Robert Lefkowitz Integral Molecular Secures Nearly $900K in NIH Funding
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
Learn to tie your program's progress directly to your funding runway, incorporating crucial early commercial
- Targeting Intracellular Allosteric Sites in GPCRs
of adjustability in terms of pharmacological effects, allowing for the administration of substantial doses














